Key result
Elevated serum levels of NT-proBNP were independently and inversely correlated with heart rate variability parameters SDNN (β = -0.060, P = 0.001) and VLF (β = -0.145, P < 0.001) in patients with unstable angina pectoris.
Why the study?
Do serum NT-proBNP levels correlate with heart rate variability parameters in patients with unstable angina pectoris?
Cross-Sectional (n=90)
No
Do serum NT-proBNP levels correlate with heart rate variability parameters in patients with unstable angina pectoris?
Elevated serum levels of NT-proBNP are inversely correlated with heart rate variability parameters (SDNN and VLF) in patients with unstable angina, suggesting a link between neurohormonal dysfunction and autonomic imbalance.
NT-proBNP elevation may signal autonomic imbalance in unstable angina; leaves open causal links and clinical utility.
We explored the relationships between heart rate variability (HRV) and levels of N-terminal Pro-B-type natriuretic peptide (NT-proBNP) in patients with unstable angina pectoris (UA).A total of 90 consecutive patients admitted < 48 hours for UA were included. Serum levels of NT-proBNP were measured from blood samples. The cohort was divided into tertiles according to NT-proBNP levels. HRV parameters including SDNN, RMSSD, LF, HF, TP, and VLF were assessed by 24-hour Holter ECG monitoring.The median (IQR) NT-proBNP level was 177.02 (64.76, 740.70) pg/mL. Patients with SDNN < 100 ms had higher levels of NT-proBNP than those with SDNN > 100 ms (P = 0.003). With increasing levels of NT-proBNP, both the 24hour monitoring HRV and night-monitoring HRV showed that SDNN and VLF gradually decreased (P < 0.01), and patients in the NT-proBNP lowest tertile group had higher LF values than the other two groups (P < 0.05); however, no difference was found in RMSSD, HF, and TP. During the daytime, the LF, VLF, and TP values were lower in the NTproBNP highest group compared with the lowest tertile group (P < 0.05). NT-proBNP levels correlated negatively with SDNN (r = -0.314, P = 0.003) and VLF (r = -0.397, P < 0.001) but not with other HRV parameters. Multiple regression analysis showed that serum levels of NT-proBNP remained predictive of SDNN (β = -0.060, P = 0.001) and VLF (β = -0.145, P < 0.001), even after adjustment for confounders.Our study showed that the elevated serum levels of NT-proBNP predict reduced HRV parameters, and the increased NT-proBNP levels combined with decreased HRV represent the degree of neurohormonal dysfunction and may be better prognostic predictors for risk stratification in UA patients.
No takes yet. Share an insight, caveat, or question.
Du-Fang et al. (2016) conducted a cross-sectional in Unstable Angina Pectoris (n=90). Elevated serum NT-proBNP levels vs. Lower serum NT-proBNP levels was evaluated on Correlation between NT-proBNP levels and heart rate variability parameter SDNN (β = -0.060, p=0.001). Elevated serum levels of NT-proBNP were independently and inversely correlated with heart rate variability parameters SDNN (β = -0.060, P = 0.001) and VLF (β = -0.145, P < 0.001) in patients with unstable angina pectoris.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: